Related Experiment Video
Updated: Jan 9, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Pregnancy management for patients with bleeding disorders.
Nidhi Patel1, Bethany Samuelson Bannow2
1Department of Internal Medicine, Providence Portland, Portland, OR.
Pregnant individuals with bleeding disorders face higher postpartum hemorrhage risks. Multidisciplinary care and timely factor level monitoring are crucial for managing bleeding during and after pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Maternal-Fetal Medicine
Background:
- Pregnant persons with bleeding disorders (pwBD) have increased risks of postpartum hemorrhage (PPH).
- Pregnancy-induced hypercoagulable state may not ensure adequate hemostasis in pwBD with von Willebrand disease, qualitative platelet defects (QPDs), or hemophilia carriers (HC).
- Multidisciplinary care involving hematologists, obstetricians, anesthesiologists, and geneticists is beneficial for pwBD.
Purpose of the Study:
- To outline the risks and management strategies for pregnant persons with bleeding disorders.
- To emphasize the importance of multidisciplinary care and factor level monitoring.
- To discuss hemostatic therapies and delivery considerations for pwBD.
Main Methods:
- Review of current literature and clinical practices for managing bleeding disorders in pregnancy.
- Emphasis on obtaining baseline and antepartum factor levels for delivery planning.
- Discussion of various hemostatic therapies, including antifibrinolytics, desmopressin, factor concentrates, and blood products.
Main Results:
- Target factor levels for delivery remain controversial due to unpredictable phenotype-level correlation.
- Antifibrinolytic agents like tranexamic acid show robust evidence for PPH management.
- Factor concentrates are increasingly used, with blood products as alternatives for QPDs or when concentrates are unavailable.
Conclusions:
- Mode of delivery should prioritize maternal indications, considering risks to both mother and neonate, especially for HCs.
- Postpartum therapies may require continuation for weeks due to the high risk of delayed PPH.
- Proactive, multidisciplinary management is essential for optimizing outcomes in pwBD.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Mitral Valve Prolapse III: Nursing Management

